NCM
ELOX

Nantahala Capital Management’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Nantahala Capital Management’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-19,369
Closed -$434K – 139
2022
Q1 		$434K Sell
19,369
-2,997
-13% -$59K 0.02% 108
2021
Q4 		$632K Sell
22,366
-7,867
-26% -$343K 0.02% 121
2021
Q3 		$1.97M Sell
30,233
-26,424
-47% -$1.63M 0.06% 108
2021
Q2 		$4.51M Buy
+56,657
New +$4.73M 0.13% 93

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Nantahala Capital Management's ELOX Position: Q2 2022 in Review

Nantahala Capital Management sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2022, closing a stake of 19,369 shares — an estimated $434K sold.

Nantahala Capital Management first reported a position in ELOX in Q2 2021 and held it in 4 quarters. The position peaked at $4.51M in Q2 2021. 30 funds tracked by Wall St. Rank hold ELOX as of Q2 2022.

  • Nantahala Capital Management reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Nantahala Capital Management sold 19,369 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $434K.
  • Nantahala Capital Management first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Nantahala Capital Management's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $4.51M in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Nantahala Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.